openPR Logo
Press release

Chronic Obstructive Pulmonary Disease Market size was valued at USD 12.4 Billion in 2021, growing at a CAGR of 6.90% from 2022 to 2032: Evolve Business Intelligence

10-12-2022 10:12 PM CET | Health & Medicine

Press release from: Evolve Business Intelligence

Chronic Obstructive Pulmonary Disease Market size was valued

The global Chronic Obstructive Pulmonary Disease market size was valued at USD 12.4 Billion in 2021 growing at the CAGR of 6.90% from 2022 to 2032. Evolve Business Intelligence provides an in-dept research study that contains the ability to focus on the major market dynamics in several region across the globe. Moreover, a details assessment of the market is conducted by our analysts on various geographic including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to provide clients with opportunity to dominate the emerging markets. The Chronic Obstructive Pulmonary Disease market study includes growth factors, restraining factors, challenges, and Opportunities which allows the businesses to assess the market capability of the industry. The report delivers market size from 2020 to 2032 with forecast period of 2022 to 2032. The report also contains revenue, production, sales consumption, pricing trends, and other factors which are essential for assessing any market.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=015997

Key Highlights:
• The global Chronic Obstructive Pulmonary Disease market size was valued at USD 12.4 Billion in 2021 growing at the CAGR of 6.90% from 2022 to 2032.
• North America dominated the market in 2021
• Asia Pacific is expected to grow at a highest CAGR from 2022 to 2032

Key Players
The Chronic Obstructive Pulmonary Disease market report gives comprehensive information about the company and its past performance. The report also provide a detail market share analysis along with product benchmarking with key developments.

The key players profiled in the report are:
● Abbott Laboratories
● Almirall
● Astellas Pharma
● AstraZeneca
● Boehringer Ingelheim
● Circassia Pharmaceuticals
● GlaxoSmithKline
● Novartis AG
● Pfizer, Inc.
● Teva Pharmaceutical Industries Ltd

The Global Chronic Obstructive Pulmonary Disease Logistic report also includes information on company profiles, product descriptions, revenue, market share data, and contact details for several regional, global, and local companies. Due to increased technological innovation, R&D, and M&A operations in the sector, the market is becoming more popular in particular niche sectors. Additionally, a large number of regional and local vendors in the Chronic Obstructive Pulmonary Disease market provide specialised product offerings according to geographical regions in keeping with the global manufacturing footprint. Due to the reliability, quality, and technological modernity of the worldwide suppliers, it is difficult for the new market entrants to compete.

COVID Impact
In terms of COVID 19 impact, the Chronic Obstructive Pulmonary Disease market report also includes the following data points:
● COVID19 Impact on Chronic Obstructive Pulmonary Disease market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in the Chronic Obstructive Pulmonary Disease market

Get a Free Sample Copy of This Report @ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=015997

Scope of the Report:
Market Segment By COPD Type:
o Emphysema
o Chronic Bronchitis

Market Segment By Treatment Type:
o Drugs
o Surgery and Oxygen Therapy

Market Segment By End User:
o Hospitals & Clinics
o Home Care Settings
o Others

For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=015997

Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of MEA)
● Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Reasons to Buy this Report:
• Detail analysis of the impact of market drivers, restraints, and oppotunities
• Competitive Intelligence providing the understanding about the ecosystem
• Details analysis of Total Addressable Market (TAM) of your products
• Investment Pockets and New Business Opportunities
• Demand-supply gap analysis
• Strategy Planning

Contact Us:
Evolve Business Intelligence
India
Contact: +1 773 644 5507 (US) / +441163182335 (UK)
Email: sales@evolvebi.com
Website: www.evolvebi.com

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Obstructive Pulmonary Disease Market size was valued at USD 12.4 Billion in 2021, growing at a CAGR of 6.90% from 2022 to 2032: Evolve Business Intelligence here

News-ID: 2765886 • Views:

More Releases from Evolve Business Intelligence

HVAC System Market Forecast to Reach USD 412.35 Billion by 2033
HVAC System Market Forecast to Reach USD 412.35 Billion by 2033
The global HVAC system market is a significant and growing industry, with a projected market size of USD 412.35 Billion by 2033, up from USD 284.35 Billion in 2023. This represents a strong Compound Annual Growth Rate (CAGR) of 7.65% over the period from 2023 to 2033. Within this expansive market, ventilation stands out as a high-opportunity segment. With a growing focus on indoor air quality (IAQ), energy efficiency, and
Frozen Food Packaging Market Forecast to Reach USD 62.74 Billion by 2033
Frozen Food Packaging Market Forecast to Reach USD 62.74 Billion by 2033
The global frozen food packaging market is a dynamic industry, constantly seeking innovative, sustainable, and cost-effective solutions. While traditional materials like plastics and aluminum have dominated the sector, there is a burgeoning opportunity for wood-based packaging to revolutionize the industry. With a growing consumer preference for eco-friendly products and an increasing focus on sustainable supply chains, wood presents a unique and high-potential alternative. Download the full report now to discover market
E-commerce Packaging Market Forecast to Reach USD 75.61 Billion by 2034
E-commerce Packaging Market Forecast to Reach USD 75.61 Billion by 2034
The global frozen food packaging market is poised for significant expansion, with a projected growth from approximately USD 48.89 billion in 2024 to around USD 75.61 billion by 2034, representing a compound annual growth rate (CAGR) of 5.6%. This robust growth is primarily fueled by the e-commerce sector, which has transformed consumer shopping habits and created a prime opportunity for frozen ready meals. Busy lifestyles, urbanization, and a rising demand
Distributed Manufacturing Market Forecast to Reach USD 32.85 Billion by 2033
Distributed Manufacturing Market Forecast to Reach USD 32.85 Billion by 2033
The distributed manufacturing market is a rapidly expanding sector, with its value projected to grow from USD 19.74 billion in 2023 to USD 32.85 billion by 2033, a Compound Annual Growth Rate (CAGR) of 4.87%. This growth is driven by technological advancements like 3D printing and the need for more sustainable practices. Within this landscape, the Power Generation industry is emerging as a dominant force, poised to both benefit from

All 5 Releases


More Releases for Chronic

Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030 This latest report researches the industry structure,
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991 This latest report researches the
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them